Literature DB >> 21805027

Nrf2 activation diminishes during adipocyte differentiation of ST2 cells.

Dionysios V Chartoumpekis1, Panos G Ziros, Gerasimos P Sykiotis, Apostolos Zaravinos, Agathoklis I Psyrogiannis, Venetsana E Kyriazopoulou, Demetrios A Spandidos, Ioannis G Habeos.   

Abstract

Adipocyte differentiation (adipogenesis) is a highly controlled process known to be affected, among other factors, by the redox status of the cell. Nrf2 (NFE2-related factor 2) is a transcription factor that orchestrates the expression of a battery of antioxidant and detoxification genes under both basal and stress conditions. The present study investigated the activation of Nrf2 during adipocyte differentiation using as a model the mouse bone marrow-derived ST2 cell line. Treatment of ST2 cells with a differentiation cocktail containing IBMX, indomethacin, hydrocortisone and insulin induced differentiation into adipocytes over 5 days. During adipogenesis, the intracellular glutathione redox potential, which is an indicator of oxidative stress levels, became steadily more oxidized, as shown by real-time measurement in differentiating ST2 cells stably transfected with a redox-sensitive Grx1-roGFP2 fusion protein. The nuclear abundance of Nrf2 was assessed by Western immunoblotting and its DNA binding activity by EMSA (electrophoretic mobility shift assay) performed on nuclear protein extracts prepared every 24 h. The nuclear abundance of Nrf2 continuously decreased during adipogenesis in ST2 cells. Its DNA binding activity reached a nadir during the first two days of differentiation, after which it increased slightly without approaching its initial level. The pattern of Nrf2 DNA binding corresponded to its transcriptional activity as assessed in ST2 cells stably transfected with a reporter construct bearing a Nrf2 bind site upstream of the luciferase gene. In conclusion, the activation of Nrf2 decreased significantly during adipogenesis. The observed changes might lead to increased oxidative stress levels that could facilitate the differentiation process. These findings could shed new light on the pathogenesis of obesity, in which the adipose tissue and oxidative stress play prominent roles.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21805027     DOI: 10.3892/ijmm.2011.761

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  8 in total

1.  Nrf2 deletion from adipocytes, but not hepatocytes, potentiates systemic metabolic dysfunction after long-term high-fat diet-induced obesity in mice.

Authors:  Dionysios V Chartoumpekis; Dushani L Palliyaguru; Nobunao Wakabayashi; Marco Fazzari; Nicholas K H Khoo; Francisco J Schopfer; Ian Sipula; Yoko Yagishita; George K Michalopoulos; Robert M O'Doherty; Thomas W Kensler
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-02-27       Impact factor: 4.310

2.  Loss of Nrf2 accelerates ionizing radiation-induced bone loss by upregulating RANKL.

Authors:  Tapasi Rana; Michelle A Schultz; Michael L Freeman; Swati Biswas
Journal:  Free Radic Biol Med       Date:  2012-10-22       Impact factor: 7.376

Review 3.  Genetics of oxidative stress in obesity.

Authors:  Azahara I Rupérez; Angel Gil; Concepción M Aguilera
Journal:  Int J Mol Sci       Date:  2014-02-20       Impact factor: 5.923

4.  Cellular localization of NRF2 determines the self-renewal and osteogenic differentiation potential of human MSCs via the P53-SIRT1 axis.

Authors:  D S Yoon; Y Choi; J W Lee
Journal:  Cell Death Dis       Date:  2016-02-11       Impact factor: 8.469

5.  Flavonoids Activation of the Transcription Factor Nrf2 as a Hypothesis Approach for the Prevention and Modulation of SARS-CoV-2 Infection Severity.

Authors:  Patricia Mendonca; Karam F A Soliman
Journal:  Antioxidants (Basel)       Date:  2020-07-24

Review 6.  The Role of NRF2 in Bone Metabolism - Friend or Foe?

Authors:  Jie Han; Kuan Yang; Jinyang An; Na Jiang; Songbo Fu; Xulei Tang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-23       Impact factor: 5.555

Review 7.  New player on an old field; the keap1/Nrf2 pathway as a target for treatment of type 2 diabetes and metabolic syndrome.

Authors:  Dionysios V Chartoumpekis; Thomas W Kensler
Journal:  Curr Diabetes Rev       Date:  2013-03-01

8.  Dimethylfumarate suppresses adipogenic differentiation in 3T3-L1 preadipocytes through inhibition of STAT3 activity.

Authors:  Hyeon-Ji Kang; Hyun-Ae Seo; Younghoon Go; Chang Joo Oh; Nam Ho Jeoung; Keun-Gyu Park; In-Kyu Lee
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.